A study by Kudo et al. has provided evidence of a link between using KPT-9274—a dual NAMPT and PAK4 inhibitor—and the reduction of inflammation, decrease in cell growth, and downregulation of DNA-repair-related genes in platinum-resistant 3D-cultured ovarian cancers spheroids [112]. Here, PAK4 is linked to ovarian carcinoma.